What Happened?
, -based Lexaria Bioscience Appointed Nelson Cabatuan as Chief Financial Officer
About the Company
Lexaria Bioscience Corp. has developed and out-licenses its proprietary technology for improved taste, rapidity, and delivery of bioactive compounds. Lexaria has multiple patents pending and granted in over 40 countries around the world and was granted its first patent in the USA in October, 2016. Lexaria`s technology provides increases of up to 10x in intestinal absorption rates; more rapid delivery to the bloodstream with effects often within 15-20 minutes; and important taste-masking benefits, for orally administered bioactive molecules including but not limited to cannabinoids, vitamins, NSAIDs, and nicotine.
About the Person
Nelson Cabatuan is Chief Financial Officer at Lexaria Bioscience. Previously, Nelson held various senior HR leadership roles in the industry.
Info Source
News
Short Profile